Knowledge about Human Papilloma Virus (HPV) and HPV Vaccine at Reproductive Age in Primary Care

Year 2015, , 517 - 524, 30.09.2015

Özde Önder Murat Dicle Hakan Gülmez Cenk Aypak Derya Akbıyık Süleyman Görpelioğlu

https://doi.org/10.17826/cutf.53958

Abstract

Purpose: The aim of this study was to identify the knowledge and awareness about human papilloma virus (HPV) and human papilloma virus (HPV) vaccine of women in reproductive age. Material and Methods: The study covered 294 women aged between 15 and 49. A questionnaire was prepared by the researchers based on the literature review. Results: The mean age of the participants was 30.5±8.9 years. Only 24.5% had heard about HPV infection and 28.2% had heard HPV vaccine. Of the participants, 188 (63.9%) got zero point from the knowledge questions. Conclusion: This study indicates that the women who apply primary care units have low knowledge levels; it is apperent that personal and social education is needed. Paying importance to patient education on HPV and cervical cancer in primary care health politics will increase knowledge and awareness for HPV infection and HPV vaccination.

Keywords

-

Birinci Basamağa Başvuran Doğurganlık Çağındaki Kadınların Human Papilloma Virus (HPV) ve HPV Aşısı Hakkındaki Bilgi Düzeyleri

Abstract

Amaç: Bu çalışmanın amacı doğurganlık çağındaki kadınların HPV ve HPV aşısı hakkındaki farkındalık ve bilgi düzeylerini ortaya çıkarmaktır. Materyal ve Metod: Çalışmaya 15-49 yaş aralığındaki 294 kadın dahil edildi. Yazarlar tarafından literatür taranarak hazırlanan anket formunun doldurulması istendi. Bulgular: Katılımcıların ortalama yaşı 30.5±8.9 idi. Yalnızca %24.5'i HPV enfeksiyonundan, %28.2'si ise HPV aşısından haberdardı. Katılımcılardan 188'i bilgi sorularından sıfır puan aldı. Sonuç: Bu çalışma birinci basamağa başvuran kadınların düşük bilgi düzeyinde olduklarını , bireysel ve toplumsal eğitimin gerekliliğini göstermiştir. Birinci basamak sağlık politikalarında hasta eğitimine önem verilmesi toplumun bilgi ve farkındalık düzeylerini artıracak ve kanser insidansının düşmesini sağlayacaktır.

Keywords

HPV, HPV aşısı, Birinci Basamak, Bilgi Düzeyi

References

• Chinchai T, Chansaenroj J, Swangvaree S, Junyangdikul P, Poovorawan Y. Prevalence of human papilloma virus genotypes in cervical cancer. Int J Gynecol Cancer. 2012;22:1063–8.
• Garland S, Park SN, Ngan HY, Frazer I, Tay EH, Chen CH, et al. The need for public education on hpv and cervical cancer prevention ın asia. Opinions of experts at the AOGIN Conference. Vaccine. 2008;26:59–8.
• Munoz M, Camargo M, Soto-De Leon S, Rojas- Villaraga A, Sanchez R, Jaimes C, et al. The diagnostic performance of classical molecular tests used for detecting human papillomavirus. J Virol Methods. 2012;185:32–8.
• Demir ET, Ceyhan M., Simsek M, Gunduz T, Arlier S, Aytac R, et al. The prevalence of different hpv types in turkish women with a normal pap smear. J Med Virol. 2012;84:1242–7.
• Yanikkerem E, Piyan G, Kavlak T, Karadeniz G. Assessing the Role of education on Turkish university students’ knowledge about HPV and related diseases. Asian Pac J Cancer Prev. 2010;11:1703– 11.
• Giles M, Garland S. A study of women’s knowledge
• regarding human papillomavirus ınfection, cervical cancer and human papillomavirus vaccines. Aust N Z J Obstet Gynaecol. 2006;46:311–5.
• Wong LP, Wong YL, Low WY, Khoo EM, Shuib R. Knowledge and awareness of cervical cancer and screening among malaysian women who have never had a pap smear: A qualitative study. Singapore Med J. 2009;50:49–53.
• Monsonego J, Zerat L, Syrjӓnen K, Zerat JC, Smith JS, Halfon P. Prevalence of type-specific human papillomavirus infection among women in france: Implications For screening, vaccination, and a future generation of multivalent HPV vaccines. Vaccine. 2012;30:5215–21.
• Antilla A, von Karsa L, Aasmaa A, Fender M, Patnick J, Rebolj M, et al. Cervical cancer screening policies and coverage in Europe , Eur J Cancer. 2009;45:2649-58.
• Chang IJ, Huang R, He W, Zhang SK, Wang SM, Zhao FH, et al. Effect of an educational ıntervention on hpv knowledge and vaccine attitudes among urban employed women and female undergraduate students ın China: A cross-sectional study. BMC Public Health. 2013;13:916.
• Dursun P, Senger SS, Arslan H, Kuscu E, Ayhan A. Human papilloma virus (HPV) prevalence and types among Turkish women at a gynecology outpatient unit. BMC Infect Dis. 2009;9:191.
• Bayram A, Erkilic S, Balat O, Eksi F, Uğur MG, Öztürk E, et al. Prevalence and genotype distribution of human papilloma virus in nonneoplastic cervical tissue lesion: cervical erosion. J Med Virol. 2011;83:1997–2003.
• Kasap B, Yetimalar H, Keklik A, Yildiz A, Cukurova K, Soylu F. Prevalence and risk factors for human papilloma virus DNA in cervical cytology. Eur J Obstet Gynecol Reprod Biol. 2011;11:168–71.
• Kahn JA, Rosenthal SL, Hamann T, Bernstein DI. Attitudes about human papilloma virus vaccine in young women. Int J STD AIDS. 2003;14:300–6.
• Tiro JA, Meissner HI, Kobrin S, Chollette V. What Do U.S. Women papillomavirus Epidemiol Biomarkers Prev. 2007;16:288–94. human Cancer and cervical cancer?
• Hughes J, Cates JR, Liddon N, Smith JS, Gottlieb SL, Brewer NT. Disparities in how parents are learning about the human papilloma virus vaccine. Cancer Epidemiol Biomarkers Prev. 2009;18:363–72.
• Durusoy R, Yamazhan M, Taşbakan MI, Ergin I, Aysin M, Pullukcu H, et al. HPV vaccine awareness and willingness of first-year students entering university in western Turkey. Asian Pac J Cancer Prev 2010;11:1–7.
• Holcomb B, Bailey JM, Crawford K, Ruffin MT 4th. Adults’ knowledge and behaviors related to human papillomavirus infection. J Am Board Fam Pract. 2004;17:26–31.
• Al-Naggar RA, Low WY, Isa ZM. Knowledge and barriers towards cervical cancer screening among young women in Malaysia. Asian Pac J Cancer Prev. 2010;11:867–73.
• Di Giuseppe G, Abbate R, Liquori G, Albano L, Angelillo IF. Human papillomavirus and vaccination: knowledge, attitudes, and behavioural ıntention in adolescents and young women in Italy. Br J Cancer. 2008;99:225–9.
• Pitts M, Clarke T. Human papilloma virus infections and risks of cervical cancer: what do women know? Health Educ Res. 2002;17:706–14.
• Sauvageau C, Duval B, Gilca V, Lavoie F, Ouakki M. Human papilloma virus vaccine and cervical cancer screening acceptability among adults in Quebec, Canada. BMC Public Health. 2007;7:304.
• Rama CH, Villa LL, Paqliusi S, Andreoli MA, Costa MC, Aoki AL, et al. Awareness and knowledge of HPV, cervical cancer and vaccines in young women after first delivery in São Paulo, Brazil--a Cross- Sectional Study. BMC Women’s Health. 2010;10:35.
• Waller J, McCaffery K, Forrest S, Szarewski A, Cadman L, Wardle J. Awareness of human papilloma virus among women attending a well woman clinic. Sex Transm Infect. 2003;79:320 –2.
• Zimet GD. Improving Adolescent Health: Focus on HPV vaccine acceptance. J Adolesc Health. 2005 ;37:17–23.
• Wong LP. Young multiethnic women’s attitudes toward the HPV vaccine and HPV vaccination. Int J Gynaecol Obstet. 2008;103:131–5.
• Marlow L, Waller J, Wardle J. Public awareness that HPV is a risk factor for cervical cancer. Br J Cancer. 2007;97:691–4.
• Donders, GG, Gabrovska M, Bellen G, Van Keirsbilck J, Van Den Bosch T, Riphagen I, et al. Knowledge of cervix cancer, human papilloma virus (HPV) and HPV vaccination at the moment of introduction of the vaccine in women in Belgium. Arch Gynecol Obstet. 2008;277:291–8.
• Reis N, Bebis H, Kose S, Sis A, Engin R, Yavan T. Knowledge, behavior and beliefs related to cervical cancer and screening among Turkish women. Asian Pac J Cancer Prev. 2012;13:1463–70.
• Do H, Seng P, Talbot J, Acorda E, Coronado GD, Taylor VM. HPV vaccine knowledge and beliefs among cambodian american parents and community leaders. Asian Pac J Cancer Prev 2009;10:339-44.